Projects
Search from 1157 projects:
1157 Project(s)
Stromal Cell Niches at the Nexus of the Innate Lymphoid Cell Interactome
Jan 1, 2019Innate lymphoid cells (ILCs) critically impact a diverse array of diseases. While the main cell-intrinsic molecular pathways and some of the soluble mediators that regulate ILC development and their functional activity have been characterized, the ce...
Fundamental Research - Jan 1, 2019 - Dec 31, 2022
Automatically Closed
Project leader: Ludewig Burkhard
Members: Lütge Mechthild
Transcriptomic analysis of the B and T cell repertoire in Multiple Sclerosis – an exploratory study
Jan 1, 2019Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). While T cells dominate the immune response, both B and T cells contribute to the demyelination and neuronal injury that underlies clinical disease manifestatio...
Fundamental Research - Jan 1, 2019 - Jan 31, 2019
Automatically Closed
Project leader: Pikor Natalia, Ludewig Burkhard
Deciphering the transcriptomic landscape of cancer-associated fibroblasts in pancreatic cancer / Oncological Research
Jan 1, 2019Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancer types with a 5-year survival of only 7% and strongly limited treatment options. A major obstacle for successful treatment is the immunosuppressive nature of the tumor microe...
Fundamental Research - Jan 1, 2019 - Dec 31, 2021
Automatically Closed
Project leader: Ludewig Burkhard, Lütge Mechthild
Inorganic Nanoparticles with Anti-inflammatory and Antimicrobial Activity: New Prospects for Long-term Local Immunoimodulation?
Jan 1, 2019Control and eventual attenuation of inflammation is important in the management of a plethora of diseases. However, suppression of inflammatory responses, e.g. by corticosteroids or systemic blockade of immune effector pathways, is associated with se...
Fundamental Research - Jan 1, 2019 - Dec 31, 2019
Automatically Closed
Project leader: Ludewig Burkhard, Herrmann Inge
A prospective randomized, parallel-group, multicentre, superiority trial of the SUPERA peripheral stent system in patients with femoro-popliteal artery disease
Jan 1, 2019The primary objective of the study is to investigate, if the Supera® Peripheral Stent System has clinical superiority over EverFlex™ Self-Expanding Peripheral Stent System with Entrust™ Delivery System or as Protégé™ EverFlex™, a standard self-expand...
Clinical Studies - Jan 1, 2019 - Dec 31, 2025
Ongoing
Project leader: Hechelhammer Lukas
Members: Dick Florian, von Allmen Regula, Benecke Ulf, Baumer Andrea, Koeger Philipp, Stillhard Roman
I6T-MC-AMAM
Jan 1, 2019A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
Clinical Studies - Jan 1, 2019 - Dec 1, 2022
Automatically Closed
Project leader: Brand Stephan
Members: Sulz Michael, Smolders Jolijn, Krieger-Grübel Claudia
The „seed and soil“-based pathogenesis of proteasome inhibitor resistance in multiple myeloma
Jan 1, 2019Using the novel method of single-sell RNA sequencing, recently established by the Institute of Immunobiology at MFZ, KSSG, and our experience and knowledge about proteasome inhibitor resistance of myeloma plasma cells in vitro, we shall use the MFZ s...
Fundamental Research - Jan 1, 2019 - Dec 31, 2019
Automatically Closed
Project leader: Besse Lenka
Members: Besse Andrej, Schwestermann Jonas
Identification and manipulation of immune-stimulating fibroblastic stromal cell niches in the inflamed CNS
Jan 1, 2019The unique anatomy of the central nervous system (CNS) necessitates that inflammation in this organ is limited. However, emerging studies reveal that focal inflammation may be more prominent than previously appreciated. Avenues for immune surveill...
Fundamental Research - Jan 1, 2019 - Jun 30, 2023
Automatically Closed
Project leader: Pikor Natalia, Ludewig Burkhard
Prospective Observational international Registry of Patients with newly diagnosed peripheral T-Cell Lymphoma
Jan 1, 2019
Clinical Studies - Jan 1, 2019 - Dec 31, 2030
Ongoing
Project leader: Hitz Felicitas
Members: Demmer-Steingruber Ruth, Müller Fiona
A phase III trial of marizomib in combination with standard
Dec 13, 2018Marizomib in Glioblastoma
Clinical Studies - Dec 13, 2018 - Nov 13, 2021
Automatically Closed
Project leader: Hundsberger Thomas
MK-3475-495 KeyImPaCT
Dec 12, 2018Open-label randomisierte Phase II Studie, welche in der Erstlinientherapie bei Patienten mit metastasiertem NSCLC die Kombination von Pembrolizumab mit entweder MK-4280 oder lenvatinib untersucht. Ausgenommen sind Patienten für die eine zielgericht...
Clinical Studies - Dec 12, 2018 - Dec 19, 2020
Automatically Closed
Project leader: Schmid Sabine
IBCSG 55-17 “Touch” Phase II open-label, multicenter, randomized trial of neo-adjuvant palbociclib in combination with hormonal therapy and HER2 blockade versus paclitaxel in combination with HER2 blockade for elderly patients with hormone receptor positive/HER2 positive early breast cancer
Dec 4, 2018CDK4/6-Inhibitoren bringen enorme Verbesserungen bei der Behandlung von Patienten mit fortgeschrittenen, HR+ (Hormonrezeptor positiv)/HER2- (human epidermal growth factor receptor 2 negativ) BC (Brustkrebserkrankungen). Palbociclib und andere CDK4/6-...
Clinical Studies - Dec 4, 2018 - Dec 31, 2021
Automatically Closed
Project leader: Weder Patrik
„Comparing Analgesic Efficacy of Systemic Lidocaine against Placebo in General Anesthesia in Bariatric Surgery: prospective, randomized, double-blinded, placebo controlled, monocenter study” (COALAS)
Dec 1, 2018Hintergrund: Die bariatrische Chirurgie hat in den letzten Jahren eine zentrale Bedeutung in der Behandlung der morbiden Adipositas erlangt und wird auch an unserem Spital regelmässig durchgeführt. Anästhesiologisch ist die Betreuung dieser Patienten...
Clinical Studies - Dec 1, 2018 - Dec 31, 2020
Automatically Closed
Project leader: Filipovic Miodrag
The role of physical activity, malnutrition and sarcopenia for the prediction of acute exacerbations and the evolution of COPD assessment test (CAT) in patients with COPD
Nov 29, 2018We plan to investigate the association between physical activity, malnutrition and sar-copenia and the occurrence of acute exacerbations of COPD (AECOPD) / the evolution of the COPD assessment test (CAT) over 1 year in a telehealthcare (THC) cohort o...
Clinical Studies - Nov 29, 2018 - Jun 30, 2021
Completed
Project leader: Bösch Maximilian
Members: Baty Florent, Rassouli Frank, Tschirren Ursina, Widmer Sandra, Bilz Stefan, Brutsche Martin
Does custom-made total knee arthroplasty better restore normal gait than conventional total knee arthroplasty?
Nov 21, 2018tbd
Fundamental Research - Nov 21, 2018 - Dec 31, 2020
Automatically Closed
Project leader: Behrend Henrik
Members: Zdravkovic Vilijam
Differences in adherence to national target criteria for good disease management in tertiary diabetes care: Challenges and/or unmet needs?
Nov 1, 2018Earlier this year we published the first evaluation, to our knowledge, of adherence to the national target criteria for good disease management in diabetes in tertiary diabetes care. The study was based on the Swiss Diabetes Registry (SwissDiab), an...
Clinical Studies - Nov 1, 2018 - Oct 31, 2019
Automatically Closed
Project leader: Brändle Michael
Members: Renström Frida
BIOSOLVE IV - Safety and Performance in de Novo Lesions of Native Coronary Arteries with Magmaris
Nov 1, 2018The aim of the BIOSOLVE - IV Swiss Satellite Registry is to investigate the clinical performance and long-term safety of Magmaris in a real world setting and extend clinical practice using the technology in a monitored nationwide registry. Primary En...
Clinical Studies - Nov 1, 2018 - Mar 31, 2022
Aborted
Project leader: Jörg Lucas
Members: Schneider Irene
TLD-1, a novel Liposomal Doxorubicin, in Patients with Advanced Solid Tumors; a multicenter open-label single-arm phase I trial.
Oct 26, 2018In dieser Studie wird zum ersten Mal die Sicherheit und Wirksamkeit eines neuen Medikaments (Talidox) bei Menschen untersucht. Bei dem neuen Medikament handelt es sich um einen bekannten Wirkstoff, das Chemotherapeutikum Doxorubicin, welches in einer...
Clinical Studies - Oct 26, 2018 - Dec 31, 2026
Ongoing
Project leader: Hess Dagmar
Members: Harder Anja, Quinter Janine
Trial SAKK 19/17: First line durvalumab in patients with PD-L1 positve, advanced NSCLC with performance status 2 unsuitable for combination chemotherapy. A multicenter, single-arm phase II trial
Oct 23, 2018Lung cancer is the leading cause of cancer deaths. An estimated 30 to 40% of patients diagnosed with NSCLC have a poor PS defined as a score of 2 or higher on the ECOG scale. PS 2 patients are often underrepresented in clinical trials despite represe...
Clinical Studies - Oct 23, 2018 - Nov 23, 2021
Automatically Closed
Project leader: Früh Martin
SAKK 57/16. NAPAGE NAb-PAclitaxel and GEmcita-bine in advanced soft tissue sarcoma. A multicenter open-label single arm phase Ib/IIa trial
Oct 2, 2018Multizentrische Phase Ib/IIa Studie für Patientinnen und Patienten mit metastasiertem Weichteilsarkom, welche bereits eine oder zwei palliative Chemothera-pien erhalten haben. Zunächst erfolgt eine Dosisfin-dung mit Nab-Paclitaxel and Gemcitabine un...
Clinical Studies - Oct 2, 2018 - Oct 9, 2021
Automatically Closed
Project leader: Rothermundt Christian